Cell & Gene therapy long term follow up & future directions – leveraging AI, Real World Data and decentralised delivery models

Cell & Gene therapy long term follow up & future directions – leveraging AI, Real World Data and decentralised delivery models

Tuesday, March 19, 2024 1:40 PM to 2:00 PM · 20 min. (Europe/London)
Cell Therapy [Track 3]
Presentation
ICON PLC74ICON plc is a world-leading clinical research organisation powered by healthcare intelligence. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organisations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in Dublin, Ireland, ICON employed approximately 41,150 employees in 106 locations in 53 countries as at September 30, 2023. For further information about ICON, visit: www.iconplc.com.

Documents & Links

Cell & Gene therapy long term follow up & future directions – leveraging AI, Rea

Registered attendees

Danielle Fairbrass
Danielle Fairbrass
Group Lead, Cell Biologycoding.bio
Günter Harms
Günter Harms
Senior Director, Patient Access, Germany, Austria, SwitzerlandNovartis Gene Therapies
Isaak Decoene
Isaak Decoene
Postdoctoral researcherKU Leuven

Log in

See all the content and easy-to-use features by logging in or registering!